Leonardus H.t. van der Ploeg, Chief Scientific Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 5,000 shares at $25.51 ($128K) on 2019-05-29, disclosed to the SEC on 2019-05-30.
Open-market sale of $128k RYTM by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RYTM | SELL | 2019-01-18 | $6K | — | Filing → |
| RYTM | SELL | 2018-11-06 | $1.1M | — | Filing → |
| RYTM | SELL | 2018-09-27 | $1.9M | — | Filing → |